Found 113 matching trials
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC NA Hepatocellular carcinoma (HCC) is a leading global cause of cancer-related ...
Show More Location
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma PHASE2 The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Learn More & Join Trial
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression PHASE2 This is a multicenter, single-arm, phase II clinical study evaluating the e...
Show More Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
Learn More & Join Trial
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC PHASE2 Head and neck squamous cell carcinoma (HNSCC) presents a significant clinic...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer PHASE2 This is an open-label, multicenter, single-arm Phase 2 clinical trial evalu...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer PHASE4 This study is to evaluate the efficacy and safety of chemotherapy combined ...
Show More Location
Multiple Locations
Learn More & Join Trial
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma PHASE4 Vessels that encapsulate tumor clusters (VETC) is an invasive metastatic fa...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Learn More & Join Trial
Pembrolizumab Plus Olaparib in LA-HNSCC PHASE2 The purpose of this research study is to evaluate the effectiveness of usin...
Show More Status
Active Not Recruiting
Location
Indiana University Simon Comprehensive Cancer Center
Learn More & Join Trial
A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer PHASE2 This study intends to enroll gastric cancer patients who are PD-L1 positive...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial